All News
Outgoing CDC director girds against an overhaul, and tries to calm staff nerves
In an interview, outgoing CDC Director Mandy Cohen defended the agency’s wide focus in the face of GOP criticism that it has lost its way.
Read MoreOpinion: My oral cancer shows the deep connections between chronic and infectious disease
The new administration wants “a break” from infectious disease research to focus on chronic disease.
Read MoreSTAT+: Three major health care policy issues to watch in 2025
Previewing health care policy under Trump: Medicaid cuts, Affordable Care Act premium subsidies, and Medicare reforms.
Read More(Your name here) gene therapy: new fund-raising gambit for family with rare disease
With the drug industry’s waning interest in gene therapy, a family tries a staple of philanthropy: honorary naming.
Read MoreOpinion: STAT+: How AI can help bring better care to Medicaid patients
AI can help Medicaid patients get better care. To make that possible, technology designers need to listen to people who are quite reasonably skeptical of technology.
Read MoreAster DM Healthcare launches Precision Oncology Clinics, Cancer Grid, and Onco Collect
New initiatives aim to advance cancer care through genomic medicine, collaborative research, and data-driven treatment models The post Aster DM Healthcare launches Precision Oncology Clinics, Cancer
Read MoreOne in four babies in England delivered by caesarean section, NHS data shows
Increase due to a growing number of complex births caused by rising obesity rates and women having children later in lifeOne in four babies born in NHS hospitals in England last year were delivered by
Read MoreFour Australian tourists in hospital in Fiji with suspected alcohol poisoning
Foreign affairs department updates travel advice for Fiji to include warning about risk of methanol poisoning and drink spikingFollow our Australia news live blog for latest updatesGet our breaking ne
Read MoreMixed Signals From Trials of Perioperative, Neoadjuvant Immunotherapy for Early TNBC
(MedPage Today) -- SAN ANTONIO -- Two trials of neoadjuvant immunotherapy for triple-negative breast cancer (TNBC) produced mixed efficacy signals.
Read MoreA Setback for TNBC Monitoring With Circulating Tumor DNA in ZEST Trial
(MedPage Today) -- SAN ANTONIO -- A first-in-kind trial of molecular residual disease (MRD)-guided therapy in breast cancer came to an early end because of low randomization, but insights can still
Read More